Who invested in Puma Biotechnology

4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$427Mraised across 4 rounds since 2011, from 4 sources

$70MVenture$129MRound$218MRound$10MRound

Latest round: Round, $10MMar 2022
Biggest round: $218MRound · Jan 2015
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20132015201720192021

$70MVenture$129MRound$218MRound$10MRound

First round: Venture, $70M
Biggest round: $218M
Usual gap between rounds: 2.3 years

The rounds

Mar 2022
Round$10M3 new
Source recorded
Jan 2015
Round$218M
No investor was named in the report.
From a historical funding record
Feb 2014
Round$129M
No investor was named in the report.
From a historical funding record
Oct 2011
Venture$70M
No investor was named in the report.
Reported by sec.govSEC filing: $70M sold, first sale Oct 2011

Founders and team

From Puma Biotechnology's own website and the SEC filings it signed: 10 on the team.

Heather J. BlaberSenior Vice President, Marketing
Pamela WilsonSenior Vice President, Clinical Operations
Petra RietschelSenior Vice President, Clinical Development
Roger L. StormsSenior Vice President, Sales
Douglas HuntChief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer
Gordon EsplinChief Accounting Officer
Maximo F. NouguesChief Financial Officer
Alan H. AuerbachExecutive Officer, Directori
Charles R. EylerExecutive Officeri
Richard R. PhillipsExecutive Officeri

On the board, as filediThomas R. Malley

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2011Round2014Round2015Round2022

SVB Capital

OrbiMedAdage Capital Management

Everyone who backed them

SVB CapitalVC firm1round

OrbiMedPrivate equity1round

Adage Capital ManagementAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Puma Biotechnology as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.